Jorge F. Cerezo-Gomez
San Sebastian De Los Reyes, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Beyond body surface area: CT-derived body composition as a predictor of chemotherapy toxicity and survival in pancreatic ductal adenocarcinoma: a systematic review.
Journal: Cancer treatment reviews
Published: May 16, 2026
Anakinra prevents high glucose-mediated potentiation of IL-1β-induced NLRP3 inflammasome activation, small extracellular vesicle release and vascular inflammation.
Journal: Biochemical pharmacology
Published: March 26, 2026
Anakinra prevents high glucose-mediated potentiation of IL-1β-induced NLRP3 inflammasome activation, small extracellular vesicle release and vascular inflammation.
Journal: Biochemical pharmacology
Published: March 26, 2026
Assessing LDL-C Levels and Lipid-Modifying Therapies in a Real-World Cohort of Patients with Atherosclerotic Cardiovascular Disease: The REALITY Study.
Journal: Journal of clinical medicine
Published: February 26, 2025
Current status of the immunogenicity of enzyme replacement therapy in fabry disease.
Journal: Orphanet journal of rare diseases
Published: October 10, 2024
In Silico Modeling of Fabry Disease Pathophysiology for the Identification of Early Cellular Damage Biomarker Candidates.
Journal: International journal of molecular sciences
Published: September 02, 2024
Prevalence of Helicobacter pylori infection among patients with esophageal carcinoma.
Journal: World journal of gastroenterology
Published: April 24, 2024
Screening and diagnosis of primary aldosteronism. Consensus document of all the Spanish Societies involved in the management of primary aldosteronism.
Journal: Endocrine
Published: January 25, 2024
Post-event follow-up costs in patients with atherosclerotic cardiovascular disease in Spain.
Journal: Frontiers in cardiovascular medicine
Published: October 19, 2023
Cyclosporine A in hospitalized COVID-19 pneumonia patients to prevent the development of interstitial lung disease: a pilot randomized clinical trial.
Journal: Scientific reports
Published: June 26, 2023
Evolocumab as treatment in lorlatinib-related hyperlipidemia.
Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
Published: October 28, 2022
Last Updated: 09/26/2026